Literature DB >> 24697155

Ex-vivo permeation study of chlorin e6-polyvinylpyrrolidone complexes through the chick chorioallantoic membrane model.

Romchat Chutoprapat1, Lai W Chan, Paul W S Heng.   

Abstract

OBJECTIVE: To investigate the influence of the hydrophilic polymer, polyvinylpyrrolidone (PVP) on the ex-vivo permeability of the poorly water-soluble photosensitizer, chlorin e6 (Ce6) using the chick chorioallantoic membrane (CAM) model.
METHODS: The CAM was removed from the fertilized chicken egg at embryo age of 15 days. The permeation profiles of Ce6 and PVP complexes (Ce6-PVP) at 1:0, 1:1, 1:10, 1:50 and 1:100 w/w in different pH conditions were first studied using the CAM model with Franz diffusion cell over 8 h. The solution viscosity of the formulations and apparent solubility of Ce6 were also investigated. KEY
FINDINGS: The permeability of Ce6 was found to be directly proportional to the amount of PVP used and the apparent solubility of Ce6. Permeability was only marginally affected by the solution viscosity of the formulations. The permeability of Ce6 was lowered in the acidic pH. Ce6-PVP at 1:100 w/w gave the highest percentage release of Ce6 across the CAM, with 23% at pH 3 and 55% at pH 7.4, after 8 h, respectively.
CONCLUSIONS: The present work suggests that PVP had served as penetration enhancer for the poorly water-soluble Ce6 and the CAM can serve as a useful biological membrane model for preclinical permeability study of biological and pharmaceutical substances. The Ce6-PVP formulation at 1:100 w/w can be applied for the further clinical investigation.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  chick chorioallantoic membrane; chlorin e6; permeation study; polyvinylpyrrolidone

Mesh:

Substances:

Year:  2014        PMID: 24697155     DOI: 10.1111/jphp.12222

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Fast-Dissolving Nifedipine and Atorvastatin Calcium Electrospun Nanofibers as a Potential Buccal Delivery System.

Authors:  Hassa A Alshaya; Ahmed J Alfahad; Fatemah M Alsulaihem; Alhassan H Aodah; Abdullah A Alshehri; Fahad A Almughem; Haya A Alfassam; Ahmad M Aldossary; Abdulrahman A Halwani; Haitham A Bukhary; Moutaz Y Badr; Salam Massadeh; Manal Alaamery; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2022-02-04       Impact factor: 6.321

2.  Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder.

Authors:  Manal E Alkahtani; Alhassan H Aodah; Omar A Abu Asab; Abdul W Basit; Mine Orlu; Essam A Tawfik
Journal:  Pharmaceutics       Date:  2021-06-16       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.